Papers: 10.3390/ijms22147474

https://doi.org/10.3390/ijms22147474

Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells

Cited by: 7
Author(s): Rouven Arnold, Elena Vehns, Hannah Randl, Karima Djabali
Published: about 5 years ago

Software Mentions 1